SPP1 improves risk assessment for pregnant people with PAH
Secreted phosphoprotein 1 (SPP1) levels were higher in patients with PAH, and SPP1 levels were associated with disease severity. Patients who had postpartum adverse events had higher SPP1 concentrations.
SPP1 may act as a predictor of adverse postpartum events for people with pulmonary arterial hypertension (PAH), along with other clinical indicators.
Nice article with useful insights and a friendly writing style. It’s always enjoyable to explore games that combine creativity with challenging levels. Take a look at geo dash for interesting gameplay ideas and creative platform challenges.
It’s encouraging to see research improving risk assessment for pregnant people with PAH. I often listen to research updates with a PDF voice reader.